Latest filings (excl ownership)
PRE 14A
Preliminary proxy
29 Apr 24
8-K
Regulation FD Disclosure
19 Apr 24
8-K
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
19 Apr 24
8-K
Entry into a Material Definitive Agreement
18 Apr 24
424B4
Prospectus supplement with pricing info
17 Apr 24
EFFECT
Notice of effectiveness
17 Apr 24
S-1/A
IPO registration (amended)
15 Apr 24
S-1/A
IPO registration (amended)
8 Apr 24
S-1/A
IPO registration (amended)
2 Apr 24
8-K
Entry into a Material Definitive Agreement
1 Apr 24
S-1/A
IPO registration (amended)
29 Mar 24
D
$65.00 k in equity, sold $32.50 k, 1 investor
20 Mar 24
D
$3.50 mm in debt / options / securities to be acquired, sold $3.50 mm, 1 investor
20 Mar 24
D
$341.25 k in equity, sold $195.00 k, 1 investor
20 Mar 24
D
$10.00 k in equity, sold $10.00 k, 1 investor
20 Mar 24
D
$1.00 mm in debt / options / securities to be acquired, sold $1.00 mm, 1 investor
20 Mar 24
8-K
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
18 Mar 24
10-K
2023 FY
Annual report
15 Mar 24
424B3
Prospectus supplement
12 Mar 24
8-K
Entry into a Material Definitive Agreement
12 Mar 24
424B3
Prospectus supplement
1 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
1 Mar 24
8-K
Regulation FD Disclosure
28 Feb 24
424B3
Prospectus supplement
12 Feb 24
8-K
Unregistered Sales of Equity Securities
12 Feb 24
8-K
Results of Operations and Financial Condition
7 Feb 24
424B3
Prospectus supplement
1 Feb 24
8-K
Entry into a Material Definitive Agreement
1 Feb 24
424B3
Prospectus supplement
23 Jan 24
EFFECT
Notice of effectiveness
22 Jan 24
CORRESP
Correspondence with SEC
17 Jan 24
S-1/A
IPO registration (amended)
16 Jan 24
CORRESP
Correspondence with SEC
16 Jan 24
UPLOAD
Letter from SEC
10 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
S-1/A
IPO registration (amended)
8 Jan 24
CORRESP
Correspondence with SEC
8 Jan 24
8-K
Regulation FD Disclosure
5 Jan 24
UPLOAD
Letter from SEC
21 Dec 23
8-K
Regulation FD Disclosure
19 Dec 23
Latest ownership filings
4
James A Schoeneck
22 Apr 24
3
David LaPre
12 Mar 24
SC 13G/A
683 Capital Management, LLC
14 Feb 24
SC 13G/A
First Light Acquisition Group, LLC
14 Feb 24
SC 13G/A
First Trust Capital Management L.P.
12 Feb 24
SC 13G/A
Woodline Partners LP
12 Feb 24
SC 13G/A
SPRING CREEK CAPITAL LLC
9 Feb 24
SC 13G/A
Polar Asset Management Partners Inc.
9 Feb 24
4
Alfonso G Zulueta
4 Jan 24
4
Alan R. Stewart
4 Jan 24
4
James A Schoeneck
4 Jan 24
4
Scott Leftwich
4 Jan 24
4
Allan Camaisa
4 Jan 24
4
Thomas A. Vecchiolla
26 Dec 23
3
Andrew C. Jackson
2 Nov 23
4
Heehyoung Lee
26 Oct 23
3
Alan R. Stewart
25 Oct 23
SC 13G/A
Hudson Bay Capital Management LP
10 Oct 23
SC 13D/A
Jackson Investment Group, LLC
29 Sep 23
SC 13D
Camaisa Allan
26 Sep 23
SC 13D
Leftwich Scott
26 Sep 23
3
Stephen Thesing
25 Sep 23
3
Heehyoung Lee
25 Sep 23
3
David Sans
25 Sep 23
3
Santidrian Antonio Fernandez
25 Sep 23
3
TONY T KALAJIAN
25 Sep 23
3
Scott Leftwich
25 Sep 23
3
Amish Patel
25 Sep 23
3
James A Schoeneck
25 Sep 23
3
Boris Radoslavov Minev
25 Sep 23
3
George K Ng
25 Sep 23
3
Wendy Pizarro Campbell
25 Sep 23
3
Allan Camaisa
25 Sep 23
4
William John Weber
14 Sep 23
4
Thomas A. Vecchiolla
14 Sep 23
4
Sander Gerber
14 Sep 23
SC 13G
Funicular Funds, LP
8 Sep 23
SC 13G
METEORA CAPITAL, LLC
8 Sep 23
SC 13D/A
Jackson Investment Group, LLC
28 Jun 23
SC 13G/A
683 Capital Management, LLC
14 Feb 23